KPMG Survey: New Excise Tax Will Hit Medical Device Companies Hard

Financial executives in the medical device manufacturing industry predict that a new excise tax and the burden of its related compliance costs will have a negative impact on their company bottom lines, according to a survey conducted by KPMG LLP, the audit, tax, and advisory firm.
 
Forty percent of respondents said their companies are already contemplating actions, such as price increases and cost reductions ‒ head count, manufacturing processes, or other means ‒ to stay competitive.
 
As part of the Health Care and Education Reconciliation Act of 2010, health care providers who manufacture or import medical devices or equipment for sale in the United States may be subject to a 2.3 percent excise tax. The IRS and the US Department of the Treasury issued proposed regulations pertaining to the tax in February.
 
Results of the KPMG survey show that:
  • 61 percent of the 190 financial executives from the medical device manufacturing industry said the excise tax will negatively affect their company's bottom line
  • 60 percent believe it will increase their company's tax compliance costs. 
  • 55 percent of respondents also expect that it will be difficult for their company to comply with the excise tax.
  • 16 percent cite confusion over which products will be taxable and the challenges in implementing systems for compliance as key issues.
  • 15 percent indicate that determining the tax base for each taxable device will be a compliance hurdle.
  • 13 percent noted that developing an implementation plan and determining the necessary resources required were also expected compliance hurdles.
"Manufacturers and importers of medical devices have a great deal of work to do in order to prepare to begin reporting the tax, which is effective for sales on and after the January 1, 2013, effective date and applies to their sales of taxable medical devices in the United States," said Frank Mattei, national tax leader of KPMG's Pharmaceutical and Medical Device practice. 
 
"Companies will need to become familiar with the excise tax rules, identify their affected entities and products, and develop the appropriate compliance processes. A 'gap' analysis should be conducted as soon as possible to identify areas that need to be addressed."
 
The KPMG survey also reveals that, in response to the tax, many medical device industry companies are already considering actions that they believe will help them stay competitive. 
  • 22 percent of respondents said their companies would most likely consider increasing the cost of goods sold to the purchaser.
  • 13 percent said their organizations would most likely consider making cost reductions in areas such as head count and manufacturing processes. 
  • 50 percent said they were unsure about the actions their company might take.
  • 35 percent of respondents to the KPMG survey said their company is currently working across several departments to prepare for the implementation of the excise tax regime. 
  • 9 percent said steps were being taken to prepare for the implementation within the tax department only.
  • 30 percent said they were not taking any steps to prepare because they were either still trying to understand the implications or evaluate their options.
"Companies need to work across various functions to prepare for effective compliance, because this is not just a tax issue," said Adam Uttley, a KPMG tax partner focused on accounting methods, credits, and special projects. "Finance and tax departments will need to work with their IT, operations, and regulatory counterparts, while keeping leadership informed of issues that could affect the business.
 
"Although many may still be hoping for legislative relief, it would be prudent to assume that a first deposit of medical device excise tax will be due by January 29, 2013, and the first quarterly federal excise tax return will be due by April 30, 2013," Uttley added.
 
The KPMG survey was conducted in March during a KPMG Tax practice-sponsored event focused on the impact of the medical device excise tax.
 
Related articles:

Source: Newswire Press Release
 

You may like these other stories...

Accountants who specialize in forensic and valuation services point to electronic data analysis, or big data, as the most pressing issue they’ll face in the coming months, according to results of a new survey released...
Renaissance avoided more than $6 billion tax, report saysThe Senate Permanent Subcommittee on Investigations said on Monday that a Renaissance Technologies LLC hedge fund’s investors probably avoided more than $6...
Your 15-year-old may be tech-savvy enough to debug your computer, back-up data on your mobile devices, and help you stream episodes of Game of Thrones, but chances are you can’t expect them to display the same level of...

Upcoming CPE Webinars

Jul 23
We can’t deny a great divide exists between the expectations and workplace needs of Baby Boomers and Millennials. To create thriving organizational performance, we need to shift the way in which we groom future leaders.
Jul 24
In this presentation Excel expert David Ringstrom, CPA revisits the Excel feature you should be using, but probably aren't. The Table feature offers the ability to both boost the integrity of your spreadsheets, but reduce maintenance as well.
Jul 31
In this session Excel expert David Ringstrom helps beginners get up to speed in Microsoft Excel. However, even experienced Excel users will learn some new tricks, particularly when David discusses under-utilized aspects of Excel.
Aug 5
This webcast will focus on accounting and disclosure policies for various types of consolidations and business combinations.